Royalty Pharma Plc (RPRX)
56.66
-0.50
(-0.87%)
USD |
NASDAQ |
Oct 05, 16:00
56.64
-0.02
(-0.03%)
After-Hours: 20:00
Royalty Pharma Price : 56.66 for Oct. 5, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 05, 2026 | 57.10 | 57.25 | 56.00 | 56.66 | 3.958M |
| Oct 02, 2026 | 57.64 | 57.91 | 56.96 | 57.16 | 2.229M |
| Oct 01, 2026 | 58.36 | 58.40 | 57.22 | 57.63 | 3.245M |
| Sep 30, 2026 | 58.07 | 58.64 | 57.70 | 58.36 | 3.654M |
| Sep 29, 2026 | 58.19 | 58.48 | 57.51 | 58.22 | 2.885M |
| Sep 28, 2026 | 57.88 | 58.76 | 57.63 | 58.37 | 1.863M |
| Sep 25, 2026 | 58.50 | 58.50 | 57.68 | 58.21 | 1.870M |
| Sep 24, 2026 | 57.69 | 58.87 | 57.66 | 58.29 | 2.019M |
| Sep 23, 2026 | 58.52 | 59.02 | 57.63 | 57.65 | 2.804M |
| Sep 22, 2026 | 58.27 | 59.03 | 57.86 | 58.52 | 2.692M |
| Sep 21, 2026 | 58.56 | 59.06 | 57.82 | 58.44 | 3.232M |
| Sep 18, 2026 | 58.63 | 58.96 | 57.97 | 58.41 | 7.105M |
| Sep 17, 2026 | 58.81 | 59.18 | 58.46 | 58.93 | 2.063M |
| Sep 16, 2026 | 59.00 | 59.17 | 58.27 | 58.47 | 2.158M |
| Sep 15, 2026 | 59.00 | 59.20 | 57.91 | 58.47 | 2.750M |
| Sep 14, 2026 | 58.66 | 59.55 | 57.75 | 59.05 | 2.967M |
| Sep 11, 2026 | 58.95 | 59.54 | 58.35 | 58.61 | 2.596M |
| Sep 10, 2026 | 60.44 | 60.71 | 58.64 | 58.75 | 3.325M |
| Sep 09, 2026 | 60.60 | 60.80 | 59.31 | 60.59 | 4.345M |
| Sep 08, 2026 | 59.21 | 60.86 | 58.63 | 60.59 | 8.632M |
| Sep 04, 2026 | 63.55 | 64.38 | 63.43 | 63.96 | 3.403M |
| Sep 03, 2026 | 63.56 | 63.94 | 62.50 | 63.88 | 2.761M |
| Sep 02, 2026 | 62.66 | 63.28 | 62.03 | 63.11 | 3.144M |
| Sep 01, 2026 | 61.82 | 62.58 | 61.61 | 62.32 | 2.629M |
| Aug 31, 2026 | 60.80 | 61.68 | 60.39 | 61.41 | 3.895M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| AstraZeneca PLC | 156.53 |
| Johnson & Johnson | 252.93 |
| Merck & Co., Inc. | 139.54 |
| Viatris, Inc. | 17.62 |
| ANI Pharmaceuticals, Inc. | 72.58 |
Price Related Metrics
| PE Ratio | 30.16 |
| PS Ratio | 11.74 |
| Price to Book Value | 3.696 |
| Price to Free Cash Flow | 48.61 |
| Earnings Yield | 3.32% |
| Market Cap | 25.26B |
| Operating PE Ratio | 18.84 |
| Normalized PE Ratio | 32.08 |